These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12677783)

  • 1. [HIV disease, antiretroviral treatment and the liver--emerging problems].
    Manfredi R
    Recenti Prog Med; 2003 Apr; 94(4):149-53. PubMed ID: 12677783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation in HIV/hepatitis co-infection.
    Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
    J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
    Cooper CL; Mills E
    Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
    Joly V; Yeni P
    Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coinfection with hepatitis C virus and HIV].
    Ruys TA; Reesink HW; Lange JM
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2056-60. PubMed ID: 14606352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The liver in HIV in Africa.
    Feld JJ; Ocama P; Ronald A
    Antivir Ther; 2005; 10(8):953-65. PubMed ID: 16430201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and liver diseases: recent clinical advances.
    Cengiz C; Park JS; Saraf N; Dieterich DT
    Clin Liver Dis; 2005 Nov; 9(4):647-66, vii. PubMed ID: 16207569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antiretroviral therapy on liver disease.
    Kovari H; Weber R
    Curr Opin HIV AIDS; 2011 Jul; 6(4):272-7. PubMed ID: 21508839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of hepatitis C in HIV-coinfection.
    Rockstroh JK; Vogel M
    Eur J Med Res; 2004 Jun; 9(6):304-8. PubMed ID: 15257871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of viral hepatitis on HIV infection.
    Rockstroh JK
    J Hepatol; 2006; 44(1 Suppl):S25-7. PubMed ID: 16338020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity associated with antiretroviral therapy containing HIV-1 protease inhibitors.
    Sulkowski MS
    Semin Liver Dis; 2003 May; 23(2):183-94. PubMed ID: 12800071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection and advanced age emerging epidemiological, clinical, and management issues.
    Manfredi R
    Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of lopinavir/ritonavir for the treatment of HIV-infection.
    Vogel M; Rockstroh JK
    Expert Opin Drug Saf; 2005 May; 4(3):403-20. PubMed ID: 15934849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
    Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
    Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG
    Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.